您的位置: 首页 > 农业专利 > 详情页

NOVEL ANTINEOPLASTIC DRUG BASED ON SPECIFICITY OF CANCER-CELL METABOLISM
专利权人:
DELTA-FLY PHARMA; INC.
发明人:
Hiromi WADA,Reo HAMAGUCHI
申请号:
US16096859
公开号:
US20200138855A1
申请日:
2017.07.20
申请国别(地区):
US
年份:
2020
代理人:
摘要:
An object of the present invention is to provide a method for treatment or prevention of cancer, which not only exerts a great effect at low cost but also has few side effects.A combination drug containing a urinary alkalinization agent and vitamin C or a combination drug containing a urinary alkalinization agent, vitamin C and metformin for use in treatment or remission of cancer.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充